Shensongyangxin Capsules for Paroxysmal Atrial Fibrillation: A Systematic Review of Randomized Clinical Trials

OBJECTIVE: To evaluate the evidence for the effectiveness and safety of Shensongyangxin Capsules (SSYX) for treating paroxysmal atrial fibrillation (PAF). METHODS: We searched for randomized clinical trials for SSYX in PAF up to June 2015. The Cochrane risk of bias tool was used to assess the method...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Guang, Wei, Benjun, Wang, Jie, Feng, Bo, Li, Zhaoling, Zhang, Zhenpeng, He, Qingyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801382/
https://www.ncbi.nlm.nih.gov/pubmed/26999010
http://dx.doi.org/10.1371/journal.pone.0151880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801382/
https://www.ncbi.nlm.nih.gov/pubmed/26999010
http://dx.doi.org/10.1371/journal.pone.0151880

Ejemplares similares